Ondansetron
Product Images NDC 11819-371

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 11819-371). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by United States Department Of Health & Human Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Single Dose Package (11819 371 01 Label 1)

Ondansetron Orally Disintegrating Tablet USP 8 mg single tablet label showing NDC 11819-371-01, manufactured by Mylan Pharmaceuticals Inc. The label includes storage instructions at controlled room temperature, lot number, expiration date, and handling instructions advising to peel backing off the blister without pushing the tablet through.*

FDA Label Image

Package Of 5 (11819 371 28 Label 1)

Ondansetron Orally Disintegrating Tablets USP 8 mg printed label showing NDC 11819-371-28 and package size of 5 packs. Packaged by HHS Supply Service Center in Perry Point, MD, and manufactured by Mylan Pharmaceuticals Inc. Storage instructions at controlled room temperature are also visible.*

FDA Label Image

Ondansetron Structural Formula (Image 03)

Chemical structure diagram of Ondansetron showing its molecular framework with aromatic rings and various functional groups as part of its composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.